Pyrrolidine derivative hair growth compositions and uses
申请人:GPL NIL Holdings, Inc.,
公开号:US20010049381A1
公开(公告)日:2001-12-06
This invention relates to pharmaceutical compositions and methods for treating alopecia and promoting hair growth using pyrrolidine derivatives.
这项发明涉及使用吡咯烷衍生物治疗脱发并促进头发生长的药物组合物和方法。
Method for treating nerve injury caused as a result of surgery
申请人:——
公开号:US20030203890A1
公开(公告)日:2003-10-30
The present invention relates generally to methods for treating or preventing nerve injury in a warm-blooded animal caused as a consequence of surgery by administering neurotrophic compounds described below. The invention relates more specifically to methods for treating or preventing nerve injury caused as a consequence of prostate surgery as well as erectile dysfunction.
STEM-LIKE CELLS AND METHOD FOR REPROGRAMMING ADULT MAMMALIAN SOMATIC CELLS
申请人:Weinstein David E.
公开号:US20100317711A1
公开(公告)日:2010-12-16
A new use is provided for small molecule inhibitors of Oct4 and Sox 2 as a cellular reprogramming agent and a method of reprogramming adult mammalian somatic cells into stem-like cells is provided, using small molecule inhibitors of Oct4 and Sox 2 without the need of any material derived from embryos or fetuses, and without the need of potentially harmful transfecting vectors. Stem-like cells created by the present invention can be induced to differentiate into terminally differentiated adult somatic cells, such as, for example, neuronal cells.
Pyrrolidine derivatives for vision and memory disorders
申请人:Guilford Pharmaceuticals Inc.
公开号:US20010034362A1
公开(公告)日:2001-10-25
This invention relates to pharmaceutical compositions and methods for treating a vision disorder, improving vision, treating memory impairment, or enhancing memory performance using pyrrolidine derivatives.
Small molecule inhibitors of rotamase enzyme activity
申请人:Hamilton S. Gregory
公开号:US20050272780A1
公开(公告)日:2005-12-08
This invention relates to neurotrophic N-glyoxyl-prolyl ester compounds having an affinity for FKBP-type immunophilins, their preparation and use as inhibitors of the enzyme activity associated with immunophilin proteins, and particularly inhibitors of peptidyl-prolyl isomerase or rotamase enzyme activity.